Faculty

Institution

Unit

Venue

Louis L. Pisters

Professor

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Palliative, Rehabilitation And Integrative Medicine

Department Of Neurosurgery

Division Of Surgery

Department Of Urology

Department Of Neurosurgery

Division Of Surgery

Louis L. Pisters is currently serving as a Neurosurgery Professor at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Louis L. Pisters

The University of Texas MD Anderson Cancer Center

Professor

You can click a keyword to filter the displayed items

urology oncology prostate cancer surgical oncology radiation oncology surgery cancer care prostatic disease genitourinary cancers cancer research cancer treatment bladder cancer tumor biology surgical pathology medicine cancer biology metastasis radiation therapy cancer imaging outcomes research cancer cells oncogenes reconstructive microsurgery cancer management kidney cancer jama oncology radical prostatectomy germ cells medicinal research brachytherapy histopathology reconstructive urology salvage cryotherapy cancer discovery vascular biology urogynecology benign prostatic hyperplasia renal cell carcinoma radical cystectomy cold registry robot-assisted surgery tumoral pathology urological research localized prostate cancer active surveillance clinical transplantation pharmacotherapy molecular cancer tumor suppressors cancer genetics clinical radiation oncology malignant disease biochemical failure external beam radiotherapy urogenital radiology recurrent prostate cancer salvage prostatectomy lymphoid neoplasia tumor heterogeneity cohort studies preoperative chemotherapy minimally invasive procedures hematological malignancies laparoscopy prognosis therapeutic efficacy geriatric urology cancer prevention surgical management hormonal therapy focal therapy biochemical disease-free survival radiation therapy planning female urology stress management selenium deficiency cancer letter scleroderma anatomical pathology orthopedic surgery spinal cord injury thoracic surgery vascular surgery surgical education sarcoma pediatric urology microsurgery gross anatomy neurosurgery neuro-oncology plastic surgery nephrology radiology orthopaedic surgery gastrointestinal surgery neuromuscular medicine clinical research

Notable Scholarly Works

Notable Federal Grants

Collaborators

Low Testosterone Levels and Grade Group Progression Among Localized Prostate Cancer Patients on Active Surveillance: A Retrospective Cohort Study. The Journal of Urology (2026)

active surveillanceradiation oncologylow testosterone levelscancer screeninggenitourinary cancersprostate cancerprostatic diseasejama oncologygrade group progressionurologycancer careoncology

Sex Differences in the Association of Emotional Approach Coping With Stress and Quality of Life Among Patients With Renal Cell Carcinoma. Palliative & Supportive Care (2026)

mental healthemotional selfregulationpsychosocial researchsex differencesrenal cell carcinomapsychiatryquality of lifepsychosocial factorsemotional approachsocial-emotional wellbeingpsychological traumacancer carepsychology

Bilateral Germ Cell Tumor of the Testis: Biological and Clinical Implications for a Stem Versus Genetic Origin of Cancers. Cells (2025)

pathologyclinical implicationssarcomasurgical pathologygynecologycarcinogenesishistopathologygerm cellsanatomical pathologytumoral pathology

Does Inclusion of Grade Group 1 Core Volume at Time of Fusion Biopsy Impact Rate of Adverse Pathology at Radical Prostatectomy?. Urologic Oncology Seminars and Original Investigations (2025)

radiation oncologysurgical oncologysurgical pathologyprostate cancergenitourinary cancersoutcomes researchprostatic diseaseurologycancer careoncology

Grade Group 1 Core Volume at Time of Biopsy is Not Associated With Rate of Adverse Pathology at Radical Prostatectomy. JU Open Plus (2025)

radiation oncologyradical prostatectomysurgical oncologysurgical pathologyprostate cancergenitourinary cancersprostatic diseasecore volumegrade group 1urologycancer careoncology

High-Dose Chemotherapy for Multiply or Poor-Risk Relapsed Germ Cell Tumors. Clinical Cancer Research (2025)

pathologyradiation oncologyhigh-dose chemotherapysurgical oncologycancer researchjama oncologyurologycancer treatmentcancer managementoncology

Post-Chemotherapy Retroperitoneal Lymph Node Dissection for Metastatic Testicular Cancer at a National Referral Centre. Cancers (2025)

gynecologic oncologymetastasisradiation oncologybladder cancersarcomasurgical oncologysurgical pathologyprostate cancergynecologycancer imaginghistopathologyjama oncologygynecologic cancersanatomical pathologyurologycancer careoncology

Randomized Phase 2 Trial of Presurgical Androgen Deprivation Therapy With or Without Axitinib in Prostate Cancer Presenting With Lymph Node Metastasis. European Urology Oncology (2025)

metastasisradiation oncologyendocrine-related cancerslymph node metastasiscancer treatmentsurgical oncologyphase 2genitourinary cancersprostate cancerprostatic diseaseurologypharmacotherapycancer careoncology

705P Subsequent Malignant Neoplasms (Smn) in Patients With Germ Cell Tumor of the Testis (Tgct): Implications on a Genetic vs Stem Cell Origin of Cancers. Annals of Oncology (2024)

oncogenespathologyradiation oncologytumor biologymalignant diseasesubsequent malignant neoplasmsgenetic vs stemsurgical pathologycarcinogenesiscancer researchgerm cellsgerm cell tumoroncology

A Phase II Trial of Apalutamide for Intermediate‐Risk Prostate Cancer and Molecular Correlates. British Journal of Urology (2024)

Andrew W. HahnGaniraju C. ManyamBrian F. ChapinMiao ZhangYao YuCurtis A. PettawayLisly CheryLouis L. PistersJohn F. WardJustin R. GreggJohn PapadopoulosAshish M. KamatMarisa LozanoAnh HoangBradley BroomXuemei WangChad D. HuffChristopher J. LogothetisPatricia TroncosoPatrick G. PiliéJohn W. Davis

neurologyprostate cancerpharmacologyphase ii trialintermediate-risk prostate cancerurologymolecular correlatesclinical trialsoncology

1
2
3
4
5
34
10 / page

Louis L. Pisters

Professor

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Palliative, Rehabilitation And Integrative Medicine

Department Of Neurosurgery

Division Of Surgery

Department Of Urology

Department Of Neurosurgery

Division Of Surgery

Louis L. Pisters is currently serving as a Neurosurgery Professor at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Louis L. Pisters

The University of Texas MD Anderson Cancer Center

Professor

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Low Testosterone Levels and Grade Group Progression Among Localized Prostate Cancer Patients on Active Surveillance: A Retrospective Cohort Study. The Journal of Urology (2026)

active surveillanceradiation oncologylow testosterone levelscancer screeninggenitourinary cancersprostate cancerprostatic diseasejama oncologygrade group progressionurologycancer careoncology

Sex Differences in the Association of Emotional Approach Coping With Stress and Quality of Life Among Patients With Renal Cell Carcinoma. Palliative & Supportive Care (2026)

Bilateral Germ Cell Tumor of the Testis: Biological and Clinical Implications for a Stem Versus Genetic Origin of Cancers. Cells (2025)

pathologyclinical implicationssarcomasurgical pathologygynecologycarcinogenesishistopathologygerm cellsanatomical pathologytumoral pathology

Does Inclusion of Grade Group 1 Core Volume at Time of Fusion Biopsy Impact Rate of Adverse Pathology at Radical Prostatectomy?. Urologic Oncology Seminars and Original Investigations (2025)

radiation oncologysurgical oncologysurgical pathologyprostate cancergenitourinary cancersoutcomes researchprostatic diseaseurologycancer careoncology

Grade Group 1 Core Volume at Time of Biopsy is Not Associated With Rate of Adverse Pathology at Radical Prostatectomy. JU Open Plus (2025)

radiation oncologyradical prostatectomysurgical oncologysurgical pathologyprostate cancergenitourinary cancersprostatic diseasecore volumegrade group 1urologycancer careoncology

High-Dose Chemotherapy for Multiply or Poor-Risk Relapsed Germ Cell Tumors. Clinical Cancer Research (2025)

pathologyradiation oncologyhigh-dose chemotherapysurgical oncologycancer researchjama oncologyurologycancer treatmentcancer managementoncology

Post-Chemotherapy Retroperitoneal Lymph Node Dissection for Metastatic Testicular Cancer at a National Referral Centre. Cancers (2025)

Randomized Phase 2 Trial of Presurgical Androgen Deprivation Therapy With or Without Axitinib in Prostate Cancer Presenting With Lymph Node Metastasis. European Urology Oncology (2025)

705P Subsequent Malignant Neoplasms (Smn) in Patients With Germ Cell Tumor of the Testis (Tgct): Implications on a Genetic vs Stem Cell Origin of Cancers. Annals of Oncology (2024)

oncogenespathologyradiation oncologytumor biologymalignant diseasesubsequent malignant neoplasmsgenetic vs stemsurgical pathologycarcinogenesiscancer researchgerm cellsgerm cell tumoroncology

A Phase II Trial of Apalutamide for Intermediate‐Risk Prostate Cancer and Molecular Correlates. British Journal of Urology (2024)

neurologyprostate cancerpharmacologyphase ii trialintermediate-risk prostate cancerurologymolecular correlatesclinical trialsoncology

1
2
3
4
5
34
10 / page